|
End-of-day quote
Korea S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 41,900.00 KRW | -4.66% |
|
-9.11% | -27.76% |
| 02-12 | Celltrion Pharm to cancel 14 billion won worth of own shares | RE |
| 02-04 | Celltrion Pharm 2025 operating profit 56 billion won, up 50.7% from year earlier | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.31B | - | - | - | - | - |
| 46.96B | |||||
| 39.63B | |||||
| 12.07B | |||||
| 11.61B | |||||
| 9.11B |
Select your edition
All financial news and data tailored to specific country editions
